Hence then, the article about menarini group presents updated data from electra and elevate combination studies of elacestrant orserdu in patients with er her2 metastatic breast cancer mbc at the asco 2024 annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting )
Also on site :
- Is Europe heading to an energy crisis?
- Dylan O’Brien & Hudson Williams Set For Sofia Banzhaf Thriller ‘Apparatus’
- LIVE: Spain vs Serbia – World Cup 2026 friendly